The Supreme Court on April 21 ruled to preserve nationwide access to a drug used in chemical abortions, rejecting a Texas lower-court restrictions while a lawsuit continues.
Mifepristone
Supreme Court Extends Administrative Stay in Abortion Pill Legal Challenge
The U.S. Supreme Court said it would extend the administrative stay in the abortion pill dispute until April 21, temporarily keeping in place status quo federal regulations regarding the use of an abortion drug, and giving the court additional time to consider a lower court’s ruling to stay the U.S. Food and Drug Administration’s approval of the drug.
Supreme Court Temporarily Blocks Lower Court Rulings Restricting Abortion Pills Amid Legal Challenge
The U.S. Supreme Court said April 14 it would temporarily keep in place status quo federal regulations regarding the use of an abortion drug, giving the court additional time to consider a lower court’s ruling to stay the U.S. Food and Drug Administration’s approval of the drug.
Court Order Keeps Abortion Drug Available with Restrictions
A federal appeals court in a 2-1 ruling just before midnight April 12 stopped part of the recent order by a Texas judge to suspend approval of the abortion pill mifepristone but the new ruling also put restrictions on the drug’s use.
Federal Judges Issue Conflicting Rulings on FDA’s Approval of Abortion Pill
Two very different rulings on April 7 by federal judges on the abortion drug mifepristone highlight the country’s disparate views on the subject and signal that the Supreme Court will likely have to weigh in on the drugs’ future availability.
California Pulls $54M Contract from Walgreens Over Abortion Pill Ban
California Governor Gavin Newsom said on March 8 that the state will revoke its $54 million contract with Walgreens after the pharmacy giant stated it would not sell an abortion pill by mail in states that have outlawed its use.